Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Piazza

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|June 11, 2017
Validation of PDE5 as a Chemoprevention TargetGary A Piazza
Journal of Biomedical Research|August 16, 2017
The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancerKevin Lee, Gary A Piazza
The Journal of Urology|January 10, 2004
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemopreventionJoseph W Basler, Gary A Piazza
Current Colorectal Cancer Reports|March 6, 2013
Novel Therapeutics: NSAIDs, Derivatives, and PhosphodiesterasesHeather N Tinsley, Gary A Piazza
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 30, 2015
Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemopreventionAlexandra M Fajardo, Gary A Piazza
Advances in Cancer Research|February 1, 2022
PrefaceJohn P O'Bryan, Gary A Piazza
Trends in Pharmacological Sciences|December 7, 2025
Nerandomilast as the first PDE4B-selective therapy in idiopathic pulmonary fibrosisMd Ibrahim, Gary A Piazza, Fakhrul Ahsan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2013
NSAIDs inhibit tumorigenesis, but how?Evrim Gurpinar, William E Grizzle, Gary A Piazza
Frontiers in Oncology|September 30, 2022
Editorial: Targeting the Wnt/β-catenin signaling pathway in cancerSimone Patergnani, Donald J Buchsbaum, Gary A Piazza
Frontiers in Oncology|July 23, 2013
COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory DrugsEvrim Gurpinar, William E Grizzle, Gary A Piazza
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Cancer Prevention Research (Philadelphia, Pa.)|June 11, 2017
Validation of PDE5 as a Chemoprevention TargetGary A Piazza
Journal of Biomedical Research|August 16, 2017
The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancerKevin Lee, Gary A Piazza
The Journal of Urology|January 10, 2004
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemopreventionJoseph W Basler, Gary A Piazza
Current Colorectal Cancer Reports|March 6, 2013
Novel Therapeutics: NSAIDs, Derivatives, and PhosphodiesterasesHeather N Tinsley, Gary A Piazza
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 30, 2015
Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemopreventionAlexandra M Fajardo, Gary A Piazza
Advances in Cancer Research|February 1, 2022
PrefaceJohn P O'Bryan, Gary A Piazza
Trends in Pharmacological Sciences|December 7, 2025
Nerandomilast as the first PDE4B-selective therapy in idiopathic pulmonary fibrosisMd Ibrahim, Gary A Piazza, Fakhrul Ahsan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2013
NSAIDs inhibit tumorigenesis, but how?Evrim Gurpinar, William E Grizzle, Gary A Piazza
Frontiers in Oncology|September 30, 2022
Editorial: Targeting the Wnt/β-catenin signaling pathway in cancerSimone Patergnani, Donald J Buchsbaum, Gary A Piazza
Frontiers in Oncology|July 23, 2013
COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory DrugsEvrim Gurpinar, William E Grizzle, Gary A Piazza
Pageof 12